Search
for
Sort by
Research 631–660 of 1000+
- 6581 Case of Conversion from Hashimoto’s Thyroiditis to Graves’ Disease: An Unusual Sequence
- Polycystic Ovary Syndrome (PCOS) and Fertility
- COVID-19 and hypopituitarism
- Selective Pituitary Resistance to Thyroid Hormone: Clinical Hyperthyroidism with High TSH on Levothyroxine Administration in I-131 Ablated “Graves Disease”
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- Isochromosome Mosaic Turner Syndrome: A Case Report
- Brain and muscle Arnt-like protein-1 (BMAL1) controls circadian cell proliferation and susceptibility to UVB-induced DNA damage in the epidermis
- Noninvasive method for assessing the human circadian clock using hair follicle cells
- Receptor activator of NF-κB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit
- Local circadian clock gates cell cycle progression of transient amplifying cells during regenerative hair cycling
- An estrogen receptor pathway regulates the telogen-anagen hair follicle transition and influences epidermal cell proliferation.
- Cloning of wrinkle-free, a previously uncharacterized mouse mutation, reveals crucial roles for fatty acid transport protein 4 in skin and hair development
- Cardiovascular risk factors and events in women with androgen excess
- Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome
- A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2
- Assessment of the Relationship Between Serum High Molecular Weight Adiponectin Hormone Levels and Insulin Resistance in Patients with Polycystic Ovary Syndrome
- Hormonal control of 5.ALPHA.-reductase activity in hamster sebaceous glands.
- Health-related quality of life in women with polycystic ovary syndrome: A comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36)
- Mood disorders and quality of life in polycystic ovary syndrome
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Does a male polycystic ovarian syndrome equivalent exist?
- Cross-sex hormone therapy for gender dysphoria
- Studying the correlation of renin-angiotensin-system (RAS) components and insulin resistance in polycystic ovary syndrome (PCOs)
- Treatment of hyperandrogenism in women
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome
- Sertoli–Leydig cell tumors: hormonal profile after dynamic test with GnRH analogue: triptorelin represents a useful tool to evaluate tumoral hyperandrogenism
- New onset alopecia and hirsutism in a postmenopausal women
- Lack of association between clinical and biochemical hyperandrogenism in patients with polycystic ovary syndrome
- Global Adiposity and Thickness of Intraperitoneal and Mesenteric Adipose Tissue Depots Are Increased in Women With Polycystic Ovary Syndrome (PCOS)
- Assessment of the obese patient